1,2,4-triazin-5-amine | 822-69-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 三嗪类
• 英文名称: 1,2,4-triazin-5-amine
• 英文别名: 5-amino-1,2,4-triazine
• CAS: 822-69-5
• 化学式: C₃H₄N₄
• mdl: MFCD19204976
• 分子量: 96.0916
• InChiKey: XULSZEJIHQWWEB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.2
• 重原子数：
  7
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  64.7
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-溴-2,4-二甲氧基苯乙酮 、 1,2,4-triazin-5-amine 以 N,N-二甲基甲酰胺 为溶剂， 以65%的产率得到5-amino-2-(2,4-dimethoxybenzoylmethyl)-1,2,4-triazinium bromide
  参考文献：
  名称：

  Barraclough, Paul; Collard, David; Smith, Steven, Journal of Chemical Research, Miniprint, 1989, # 7, p. 1581 - 1597

  摘要：

  DOI：
• 作为产物：
  描述：

  [1,2,4]三嗪 在 potassium permanganate 、 氨 作用下， 反应 0.5h， 以95%的产率得到1,2,4-triazin-5-amine
  参考文献：
  名称：

  Liquid Ammonia/Potassium Permanganate, A Useful Reagent in the Chichibabin Amination of 1,2,4-Triazines

  摘要：

  DOI：

  10.1055/s-1985-31371

文献信息

• SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS
  申请人：GLAXOSMITHKLINE LLC

  公开号：US20150152108A1

  公开（公告）日：2015-06-04

  The present invention relates to novel substituted bridged urea compounds, corresponding related analogs, pharmaceutical compositions and methods of use thereof. Sirtuin-modulating compounds of the present invention may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders, which include, but are not limited to, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. The present invention also related to compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

  本发明涉及新型取代桥式脲化合物，相应的相关类似物，药物组合物以及其使用方法。本发明的抑制素调节化合物可用于延长细胞寿命，并治疗和/或预防各种疾病和疾病，包括但不限于与衰老或压力、糖尿病、肥胖、神经退行性疾病、心血管疾病、血液凝块疾病、炎症、癌症和/或潮红有关的疾病或疾病，以及那些会受益于增加线粒体活性的疾病或疾病。本发明还涉及包含抑制素调节化合物与另一治疗剂组合的组合物。
• [EN] SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS<br/>[FR] ANALOGUES D'URÉE PONTÉS SUBSTITUÉS EN TANT QUE MODULATEURS DE SIRTUINE
  申请人：GLAXOSMITHKLINE IP NO 2 LTD

  公开号：WO2016079709A1

  公开（公告）日：2016-05-26

  The present invention relates to novel substituted bridged urea analog compounds of Formula (I) or pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions, processes for making and use of such compounds, alone or in combination with other therapeutic agents, as Sirtuin Modulators useful for increasing lifespan of a cell, and for use in treating and/or preventing a wide variety of diseases and disorders, which include, but are not limited to, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity.

  本发明涉及一种新型的取代桥式脲类似物化合物，其化学式为（I）或其药学上可接受的盐，相应的药物组合物，制备这种化合物的方法以及单独使用或与其他治疗剂联合使用的这些化合物作为Sirtuin调节剂，可用于增加细胞寿命，并用于治疗和/或预防各种疾病和紊乱，包括但不限于与衰老或压力、糖尿病、肥胖、神经退行性疾病、心血管疾病、血液凝块紊乱、炎症、癌症和/或潮红有关的疾病或紊乱，以及那些会受益于增加线粒体活性的疾病或紊乱。
• [EN] INHIBITORS OF CELLULAR METABOLIC PROCESSES<br/>[FR] INHIBITEURS DE PROCESSUS MÉTABOLIQUES CELLULAIRES
  申请人：AGIOS PHARMACEUTICALS INC

  公开号：WO2018039972A1

  公开（公告）日：2018-03-08

  The invention provides inhibitor compounds of MAT2A that are useful as therapeutic agents for treating malignancies wherein the compounds have the general formula (I) : wherein ring A, ring B, ring C and, R1 are as described herein.

  该发明提供了MAT2A的抑制剂化合物，可作为治疗恶性肿瘤的治疗剂。这些化合物具有一般公式(I)：其中环A、环B、环C和R1如本文所述。
• [EN] HETEROCYCLIC COMPOUNDS THAT INHIBIT THE KINASE ACTIVITY OF MNK USEFUL FOR TREATING VARIOUS CANCERS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES INHIBANT L'ACTIVITÉ KINASE DE MNK UTILES POUR LE TRAITEMENT DE DIVERS CANCERS
  申请人：EFFECTOR THERAPEUTICS INC

  公开号：WO2017087808A8

  公开（公告）日：2017-09-21
• Barraclough, Paul; Collard, David; Smith, Steven, Journal of Chemical Research, Miniprint, 1989, # 7, p. 1581 - 1597
  作者：Barraclough, Paul、Collard, David、Smith, Steven、Vine, Susan J.、Wharton, Clifford J.

  DOI：——

  日期：——